Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT07505758
Recruiting Observational

Postoperative Recovery in Elderly Patients Assessed With QoR-15E

NCT07505758 · tracked via the Priya Life Science Spain tracker
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Started
2024-03-04
Last updated
2026-04-01

Condition(s) studied

Postoperative Recovery in Elderly PatientsQuality of Recovery After Elective SurgeryPerioperative Care Outcomes in Older Adults

Investigational drug(s) / intervention(s)

QoR-15E questionnaire.Clinical Frailty ScaleConfusional Assessment MethodPost-Operative Morbidity Survey

QoR-15E questionnaire.: A first QoR-15E questionnaire will be completed at baseline (T0) (before surgery). Other QoR-15E questionnaires will be completed at 24h (T1), 48h (T2), day 7 (T3) and day 30 (T4) after surgery.

Clinical Frailty Scale: The Clinical Frailty Scale will be administered before surgery to determine patients' clinical fragility

Confusional Assessment Method: We will use the "Confusional Assessment Method" to assess the presence of confusion or delirium in the immediate postoperative period.

Post-Operative Morbidity Survey: Postoperative morbidity will be collected through the POMS survey.

Study summary

Postoperative recovery in elderly patients is an important part of the surgical process and affects how patients feel after surgery. To date, recovery has been measured mostly with clinical outcomes, such as complications or length of stay, but not from the patient's perspective. The QoR-15 questionnaire was designed to assess recovery from the patient's point of view and has recently been validated in Spanish as the QoR-15E.

This study aims to evaluate postoperative recovery in patients aged 80 years and older undergoing elective surgery with hospital admission, using the QoR-15E questionnaire. Patients will complete the questionnaire before surgery and on postoperative days 1, 2, 7, and 30. Additional assessments will include frailty and delirium scales, and postoperative complications will be recorded. Mortality will be evaluated 90 days after surgery, alongside the patient's subjective perception of their recovery.

Eligibility

Sex
ALL
Min age
80 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients aged 80 years or older. * Undergoing elective surgery requiring hospital admission. * Able to understand and provide written informed consent. Exclusion Criteria: * Inability to speak Spanish. * Pre-existing cognitive impairment. * Emergency or urgent surgery. * Neurosurgical or cardiac surgical procedures. * Ambulatory (outpatient) surgery without hospital admission.

Primary outcome measure(s)

  • Postoperative quality of recovery (QoR-15E) — Preoperatively and on postoperative days 1, 2, 7, and 30
    The QoR-15E questionnaire evaluates patient-reported quality of recovery after surgery. It includes 15 items covering physical, emotional, and psychological recovery domains.

Trial sites (4)

FacilityCityRegionStatus
Hospital del Mar de Barcelona Barcelona Barcelona Recruiting
Hospital Universitari Vall d'Hebron Barcelona Barcelona Recruiting
Hospital Clinic de Barcelona Barcelona Barcelona Recruiting
Hospital de la Santa Creu i Sant Pau Barcelona Barcelona Recruiting

More Hospital Universitari Vall d'Hebron Research Institute trials in Spain

Integrative Diagnosis for SCD and Other RADs Recruiting
Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation Recruiting
Migraine and Endometriosis: The FEMININE Study Starting soon
Accelerating Referral for Thrombectomy in Acute Stroke Patients Using an Artificial Intelligence-based Software Recruiting
Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07505758 on ClinicalTrials.gov ↗ ← All trials in Spain